The Brutalist Report

MarketWatch

• Don’t expect lower prices now that the Supreme Court ruled against Trump’s tariffs [2d]
• This once-hot cancer-detection company’s stock got cut in half after a failed trial [2d]
• How you can take advantage of two stock-market trends [2d]
• CoreWeave’s stock drops. Why a $4 billion Blue Owl funding snag has investors on edge. [2d]
• Retailers could be big winners in a repeal of Trump’s tariffs. Here’s why the stocks aren’t rising. [2d]
• Why Nvidia is ‘highly motivated’ to keep investing in OpenAI [2d]
• Adding these stocks to your 401(k) could protect against crises like war with Iran [2d]
• Prediction-market ETFs may open the door to all sorts of Wall Street tomfoolery [2d]
• Business development companies’ stocks have fallen. Some look attractive for the right type of investor. [2d]
• Medicare Advantage’s once-blistering growth dropped in 2026. Here’s what that means. [2d]